BNP Paribas Exane raises Ametek stock price target to $290 on deal
BNP Paribas Exane raised Ametek's (NYSE:AME) price target to $290, citing the Indicor deal and projecting $10.60 EPS by 2028. Ametek reported Q2 2026 earnings of $2.09 per share on $2.04B revenue, beating estimates. The company also increased its commercial paper program limit to $3.5B.
How this was made
The 30-second read
Why it matters
Analyst upgrades and a new price target reflect confidence in sustained earnings momentum.
Market read
The upgrade provides a fresh catalyst for traders, especially those tracking industrial equipment stocks.
What to watch
Potential supply‑chain constraints could temper revenue growth.
Background
Ametek reported Q2 2026 results beating expectations and subsequently raised its full‑year outlook.
Ticker impact
BNP Paribas Exane raised its price target for Ametek to $290, citing higher EPS forecasts and the closing of the Indicor deal.
Potential short-term price rally toward $290 target.
Analyst upgrade with specific EPS uplift and deal closure provides a clear catalyst.
Market effects
Higher Ametek guidance may lift related industrial instrumentation stocks.
U.S. industrial sector could see modest gains.
Limited to U.S. equities; no broader macro effect.
Counterpoint
Target raise may be premature if the Indicor deal integration faces delays.
Key entities
- CompanyAmetek Inc.
Manufacturer of electronic instruments and electromechanical devices.
- Research FirmBNP Paribas Exane
Equity research analyst raising Ametek's price target.
